Friday, September 16, 2022
Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.
Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
A Look-in on Programs. Yesterday, MustGrow announced the update on the Company’s biological programs with various partners Sumitomo, Bayer, Janssen PMP, and NexusBioAg. The update includes the soil biofumigation, postharvest food preservation, and bioherbicide of the Company’s mustard-derived technology.
Soil Biofumigation. Data regarding efficacy continue to remain positive, as the Company recently extended the program with Sumitomo that we highlighted in August. Sumitomo is working with MustGrow and the EPA in the registration approval process in the U.S. along with registration in Mexico. In Chile, the country approved an Experimental Use permit and registration work has commenced. Bayer has shown positive results in laboratory and greenhouse studies, and has new trials underway and further studies planned for Europe, Asia, and Africa.
Get the Full Report
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.